Deep learning applications in translational bioinformatics.
Deep Learning Applications in Translational Bioinformatics, a new volume in the Advances in Ubiquitous Sensing Application for Healthcare series, offers a detailed overview of basic bioinformatics, deep learning, various applications of deep learning in translational bioinformatics including deep le...
| Corporate Author: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
New York, NY :
Academic Press,
2024.
|
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
Table of Contents:
- Front Cover
- Deep Learning Applications in Translational Bioinformatics
- Copyright Page
- Contents
- List of contributors
- About the editors
- 1 Deep learning ensembles in translational bioinformatics
- 1.1 Introduction
- 1.2 Basic ensembling methods
- 1.3 Application
- 1.3.1 Application of ensemble techniques to proteomics using microarray and mass spectrometry
- 1.3.2 Gene-gene interaction detection using random forest
- 1.3.3 Prediction of regulatory elements using ensemble methods
- 1.3.3.1 Further growing uses for ensemble methods in bioinformatics
- 1.4 Extensions of the ensemble method in bioinformatics
- 1.5 Ensemble theory's application to feature selection
- 1.6 Ensemble feature selection methods and stability of feature selection algorithms in bioinformatics
- 1.6.1 Stability and feature selection algorithms
- 1.7 Algorithmic ensembles for feature selection
- 1.8 Conclusion
- References
- 2 Recursive feature elimination and multisupport vector machine in healthcare analytics
- 2.1 Introduction
- 2.1.1 Motivation of the work
- 2.1.2 Contribution of the research work
- 2.1.3 Chapter organization
- 2.2 Related works
- 2.2.1 Limitation of the existing works
- 2.3 Proposed system
- 2.3.1 Description of dataset
- 2.3.2 Dimensionality reduction and feature selection methods in medical disease diagnosis
- 2.3.2.1 Filtering techniques
- 2.3.2.2 Wrapper techniques
- 2.3.2.3 Recursive feature elimination
- 2.3.3 Classification using multisupport vector machine
- 2.4 Results and discussion
- 2.4.1 Performance used in medical disease classification
- 2.4.2 Results evaluation for recursive feature elimination calculation
- 2.5 Conclusion
- References
- 3 Sensor-enabled biomedical decision support system using deep learning and fuzzy logic
- 3.1 Introduction
- 3.1.1 Background and motivation.
- 3.1.2 Research problem statement
- 3.1.3 Objectives and contributions
- 3.1.4 Chapter organization
- 3.2 Literature review
- 3.2.1 Fuzzy logic
- 3.2.1.1 Fuzzy sets and fuzzy numbers
- 3.2.1.2 Concepts of fuzzy logic approach for research study
- 3.2.1.3 Definition of fuzzy sets along with membership function
- 3.2.2 The deep learning concept
- 3.2.2.1 Convolutional neural network
- 3.2.2.2 The concept of recurrent neural networks
- 3.2.3 Biomedical decision support system
- 3.2.3.1 Electronic health records
- 3.2.3.2 The key challenges in developing biomedical decision support system
- 3.2.4 Related work on the integration of fuzzy logic and deep learning for sensor-enabled biomedical decision support systems
- 3.3 Methodology
- 3.3.1 Data collection and preprocessing
- 3.3.2 Fuzzy logic-based feature selection
- 3.3.3 Deep learning model design and implementation
- 3.3.4 Performance evaluation metrics
- 3.4 Results from experiment
- 3.4.1 Dataset description
- 3.4.2 Performance comparison with traditional machine learning methods
- 3.4.3 Case study: prediction of cardiovascular diseases
- 3.4.3.1 Fuzzy logic-based feature selection
- 3.4.3.2 Deep learning
- 3.4.4 Case study: prediction of cardiovascular diseases using fuzzy logic and deep learning
- 3.4.4.1 Dataset description
- 3.4.4.2 Fuzzy logic-based feature selection
- 3.4.4.3 Deep learning model design and implementation
- 3.4.4.4 Performance evaluation metrics
- 3.4.4.5 Results
- 3.5 Discussion
- 3.5.1 Interpretation of results
- 3.5.2 Limitations and challenges
- 3.5.2.1 Limitations
- 3.5.2.2 Challenges
- 3.5.3 Future research directions
- 3.6 Conclusion
- References
- Further reading
- 4 Prediction of Alzheimer's disease using densely convolutional neural network
- 4.1 Introduction
- 4.2 Literature review
- 4.3 Methodology.
- 4.4 Materials and tools
- 4.4.1 Dataset
- 4.4.2 Data preprocessing
- 4.4.3 Dense convolutional neural network architecture
- 4.4.4 Hyperparameters
- 4.4.5 Evaluation
- 4.5 Results and discussion
- 4.6 Conclusion
- References
- 5 Brain tumor detection from magnetic resonance imaging images using shallow convolutional neural network
- 5.1 Introduction
- 5.2 Related works
- 5.3 Methodology
- 5.3.1 Convolutional neural network models
- 5.3.2 Proposed shallow convolutional neural network
- 5.3.2.1 The architecture
- 5.3.3 Transfer learning
- 5.3.4 Support vector machine
- 5.4 Result and discussion
- 5.5 Conclusion
- References
- 6 Multiview learning with shallow 1D-CNN for anticancer activity classification of therapeutic peptides
- 6.1 Introduction
- 6.2 Related work
- 6.3 Methodology
- 6.3.1 Convolutional neural network
- 6.3.2 The proposed 1D-convolutional neural network
- 6.3.3 Feature descriptor
- 6.3.4 Sequence-based
- 6.3.5 Standard physicochemical properties
- 6.3.6 Physicochemical properties and sequence composition
- 6.4 Experimental setup
- 6.4.1 Dataset
- 6.4.2 Result discussion
- 6.4.3 Analysis of the optimal multiview learning
- 6.5 Conclusion
- References
- 7 Deep learning methods for protein classification
- 7.1 Introduction
- 7.2 Literature survey
- 7.3 Protein representation methods
- 7.3.1 Amino-acid sequence
- 7.3.2 Substitution matrix representation
- 7.3.3 Physicochemical property response matrix
- 7.4 Proposed methodology
- 7.4.1 Dataset
- 7.4.2 Proposed classification model
- 7.4.2.1 Convolutional neural network
- 7.4.2.1.1 Input layers for 2-D CNN model
- 7.4.2.1.2 Hidden layers
- 7.4.2.1.3 Output layers
- 7.5 Result and discussion
- 7.5.1 Performace evaluation metrics
- 7.5.1.1 Accuracy
- 7.5.1.2 Precision
- 7.5.1.3 Recall.
- 7.5.2 Prediction of hemolytic and nonhemolytic activity
- 7.6 Conclusion
- References
- 8 Biosensors-based identification of antibiotic resistance in bacteria
- 8.1 Introduction
- 8.2 Gonnococal antibiotic resistance
- 8.2.1 Penicillin
- 8.2.2 Tetracycline
- 8.2.3 Ciprofloxacin
- 8.2.4 Cefixime
- 8.2.5 Ceftriaxone
- 8.2.6 Azithromycin
- 8.3 Proposed work
- 8.4 Experimentation
- 8.5 Results and discussion
- 8.5.1 Learning curve
- 8.6 Conclusion
- References
- 9 Deep learning for vehement gene expression exploration
- 9.1 Introduction
- 9.2 Gene expression
- 9.3 Gene expression analysis
- 9.4 Gene expression functioning
- 9.5 Gene expression technologies
- 9.6 Microarray technique
- 9.7 Strengths and limitations of microarray
- 9.8 Strengths of microarrays
- 9.9 Limitations of microarrays
- 9.10 Microarray functioning
- 9.11 RNA-Seq technique
- 9.12 Strengths and limitations of RNA-Seq
- 9.13 Strengths of RNA-seq
- 9.14 Limitations of RNA-seq
- 9.15 RNA-Seq functioning
- 9.16 Study on RNA-Seq over microarray
- 9.17 Deep learning
- 9.18 Deep learning sets unique from neural network
- 9.19 Deep learning sets unique from machine learning
- 9.20 Deep learning architectures: convolutional neural network and recurrent neural network
- 9.21 Convolutional neural network functioning
- 9.22 Recurrent neural networks functioning
- 9.23 Deep learning for gene expression
- 9.24 Convolutional neural networks for gene expression
- 9.25 Recurrent neural network for gene expression
- 9.26 Potential of recurrent neural network over convolutional neural network for gene expression
- 9.27 Conclusion
- References
- 10 Machine learning-enforced bioinformatics approaches for drug discovery and development
- 10.1 Introduction
- 10.2 Drug discovery: an introduction and historical perspective
- 10.3 Machine learning approaches.
- 10.4 Machine learning-enforced bioinformatic tools for drug discovery
- 10.4.1 Random forest
- 10.4.2 Artificial neural network-based approaches
- 10.4.2.1 Convolutional neural networks
- 10.4.2.2 Support vector machines
- 10.4.2.3 Multilayer perception neural network
- 10.4.2.4 Recurrent neural networks
- 10.4.3 Bayesian models
- 10.5 Deep machine learning
- 10.6 Artificial intelligence
- 10.7 Machine learning-, deep learning-, and artificial intelligence-enforced bioinformatics and cheminformatics tools
- 10.7.1 Drug design, drug prediction, and optimization
- 10.7.2 Determination of the target and validation
- 10.7.3 Prophecy of drug-drug interaction
- 10.7.4 Compound screening or hit discovery
- 10.7.5 Drug repurposing
- 10.7.6 Molecular docking
- 10.7.7 Drug safety assessment
- 10.8 Challenges and opportunities
- 10.9 Conclusion
- References
- 11 Role of deep learning in predicting drug formulations and delivery systems
- 11.1 Introduction
- 11.2 Databases, deep learning tools and techniques
- 11.2.1 Establishing the dataset
- 11.2.2 Deep learning tools and techniques
- 11.3 Data processing methods
- 11.3.1 Steps involved in data preprocessing
- 11.4 Artificial intelligence algorithms and models in dosage form development
- 11.4.1 Application of artificial intelligence in pharmaceutical drug formulations
- 11.5 Conclusions and future prospects
- References
- 12 Deep learning in computer-aided drug design: a case study
- 12.1 Introduction
- 12.1.1 Drug designing approaches
- 12.1.1.1 Structure-based drug design
- 12.1.1.2 Ligand-based drug design
- 12.1.2 Why deep learning in computer-aided drug design?
- 12.2 Role of deep learning in computer-aided drug design
- 12.3 Software tools, web servers, and package
- 12.3.1 Parameters
- 12.3.2 Tools
- 12.3.3 Packages.